2023 international evidence-based guideline pcos glp-1 receptor agonist Efficacy and safety of agonists on weight management and metabolic parameters in women: a meta-analysis of randomized controlled trials Getting a grip on polycystic
Description
Oral semaglutide likewise resulted in reductions in weight during the trial

Additionally, lixisenatide was associated with fewer gastrointestinal symptoms compared to exenatide, while long-acting GLP-1RAs generally caused less nausea and vomiting but more diarrhea than short-acting agents ( 4.4 Metabolic effects GLP-1RA are emerging as highly versatile drugs, as their unraveling features now adds to a broader potential in future

The safety profile was consistent with GLP-1 class compounds

Given the risk of complications from uncontrolled diabetes, such as the increased risk of wound infections from hyperglycemia, it would be in a patients best interest to continue these medications in the perioperative setting

& Cheng, X

Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1